STAT nuclear translocation: potential for pharmacological intervention.

STAT nuclear translocation: potential for pharmacological intervention.

Item
http://www.wikidata.org/entity/Q36956743
STAT3 inhibitors for cancer therapy: Have all roads been explored?Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathwayPreclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer.A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.A molecular model for the differential activation of STAT3 and STAT6 by the herpesviral oncoprotein tip.Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disordersSilibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells.Quantitative analysis of brain nuclear phosphoproteins identifies developmentally regulated phosphorylation events.Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.
P2860

STAT nuclear translocation: potential for pharmacological intervention.

Item
http://www.wikidata.org/entity/Q36956743
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
STAT nuclear translocation: potential for pharmacological intervention.
@en
type
label
STAT nuclear translocation: potential for pharmacological intervention.
@en
prefLabel
STAT nuclear translocation: potential for pharmacological intervention.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
STAT nuclear translocation: potential for pharmacological intervention.
@en
P2093
P2860
P304
P31
P356
10.1517/14728222.11.10.1355
P407
P433
P478
P577
P698